Intestinal liner holds promise for obesity, type 2 diabetes

09/18/2011 | InternalMedicineNews.com (free registration)

A small study presented at the European Society for the Study of Diabetes found that using a duodenal-jejunal bypass liner, an implantable weight-loss device, helped improve weight and blood glucose levels in obese patients with type 2 diabetes. The intestinal sleeve also increased the levels of incretin hormones glucagon-like peptide and peptide YY.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT